- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Feb 09, 2024
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
99 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 867China Medical System Holdings | HK$11.52 | 2.3% | -14.2% | HK$28.2b | HK$18.23 | PE7.6x | E8.6% | 5.3% | ||
| 512Grand Pharmaceutical Group | HK$3.36 | 0.9% | -30.4% | HK$11.8b | n/a | PE4.9x | E8.7% | 4.2% | ||
| 2487Cutia Therapeutics | HK$6.25 | -3.8% | n/a | HK$1.9b | HK$35.42 | PS38.7x | E79.6% | n/a | ||
| 1228CANbridge Pharmaceuticals | HK$0.38 | -11.6% | -84.2% | HK$161.4m | HK$8.85 | PS1.7x | E19.7% | n/a | ||
| 950Lee's Pharmaceutical Holdings | HK$1.39 | 6.9% | -26.1% | HK$818.5m | HK$1.00 | PE21x | S13.5% | 1.2% | ||
| 15303SBio | HK$5.68 | -2.2% | -32.5% | HK$13.6b | HK$8.67 | PE6.5x | E7.5% | 1.7% | ||
| 9926Akeso | HK$40.85 | 2.4% | -8.2% | HK$34.4b | HK$55.85 | PE15.8x | E1.5% | n/a | ||
| 1666Tong Ren Tang Technologies | HK$5.30 | -1.7% | -5.4% | HK$6.8b | HK$7.44 | PE9.8x | E3.8% | 3.3% | ||
| 2096Simcere Pharmaceutical Group | HK$5.23 | 1.9% | -52.3% | HK$13.6b | HK$10.59 | PE4x | E-26.6% | 3.3% | ||
| 2181Mabpharm | HK$0.47 | 9.3% | 11.9% | HK$1.9b | n/a | PS24.8x | n/a | n/a | ||
| 1652Fusen Pharmaceutical | HK$1.34 | -2.2% | -0.7% | HK$992.4m | n/a | PS1.4x | n/a | 0% | ||
| 2142HBM Holdings | HK$1.59 | -0.6% | -44.4% | HK$1.2b | n/a | PS2.8x | n/a | n/a | ||
| 858Extrawell Pharmaceutical Holdings | HK$0.031 | 3.3% | -60.3% | HK$74.1m | n/a | PS1.1x | n/a | n/a | ||
| 6998Genor Biopharma Holdings | HK$0.90 | -10.9% | -69.2% | HK$453.7m | n/a | PS32x | n/a | n/a | ||
| 1875TOT BIOPHARM International | HK$1.61 | 0.6% | -28.4% | HK$1.2b | HK$3.80 | PS1.9x | n/a | n/a | ||
| 8049Jilin Province Huinan Changlong Bio-pharmacy | HK$1.70 | 1.8% | 42.9% | HK$952.4m | n/a | PE3.9x | n/a | 32.3% | ||
| 1498PuraPharm | HK$0.79 | -7.1% | -33.6% | HK$312.1m | n/a | PB1.4x | n/a | 0% | ||
| 2161JBM (Healthcare) | HK$0.96 | -1.0% | 21.5% | HK$795.2m | n/a | PE8.1x | n/a | 7.2% | ||
| 1889Sanai Health Industry Group | HK$0.049 | 2.1% | -43.7% | HK$157.3m | n/a | PE3.9x | n/a | 0% | ||
| 1643Modern Chinese Medicine Group | HK$0.31 | -4.6% | -41.5% | HK$186.0m | n/a | PE2.6x | n/a | 0% | ||
| 575Regent Pacific Group | HK$0.45 | -4.3% | -77.9% | HK$102.8m | n/a | PB1.2x | n/a | n/a | ||
| 719Shandong Xinhua Pharmaceutical | HK$5.40 | 8.0% | -14.8% | HK$9.7b | n/a | PE6.6x | n/a | 4.0% | ||
| 503Lansen Pharmaceutical Holdings | HK$1.79 | 0% | 23.6% | HK$750.6m | n/a | PE13x | n/a | 2.7% | ||
| 1312Kontafarma China Holdings | HK$0.032 | 0% | -33.3% | HK$178.8m | n/a | PE33x | n/a | 0% |